Home NDC 51759-513 NDC 51759-513 - Simlandi This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 51759-513
Package NDCs from labels 51759-513-21
Manufacturer Teva Pharmaceuticals USA, Inc.
Effective date 2025-12-22
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 51759-513-21 Simlandi 0.4 mL in 1 SYRINGE INJECTION, SOLUTION 0.4 mL 40 mg in 0.4mL 24 51759-513-21 Simlandi 0.4 mL in 1 SYRINGE INJECTION, SOLUTION 0.4 mL 40 mg in 0.4mL 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 51759-513 SIMLANDI (ADALIMUMAB-RYVK) KIT [TEVA PHARMACEUTICALS USA, INC.] 16 Unmatched 20250313_12f609c9-2088-bb05-e063-6394a90a9ecc.zip 51759-513 ADALIMUMAB-RYVK KIT [TEVA PHARMACEUTICALS USA, INC.] 1 Unmatched 20250523_2d19a877-1f5a-4731-800a-dddadc424080.zip